IL-17 increases the expression of CXCL1, CXCL5, CXCL6, CXCL8, and IL-6, which potentiate the immunosuppressive function of MDSCs, inhibit the intratumoral infiltration of T cells and recruit tumor-promoting macrophages and neutrophils (89). Here, IL17A is linked to neoplasm.